For years I filed sucralose under “the sweetener that did its homework.” Saccharin had its cancer scare, aspartame has its forever-argument, but sucralose always looked like the grown-up choice: zero calories, no bitter aftertaste, a stack of safety reviews thick enough to lean on. That was my assumption walking in. The science had other plans.

The fight resurfaced this month when a widely syndicated ScienceDaily writeup revisited a 2023 finding that a sucralose byproduct damages DNA, then reassured you that “later findings have complicated” the alarm. That verb, complicated, is doing a lot of quiet work. When I chased down what actually complicated it, the answer was a 2026 study that found nothing wrong, co-written by a scientist at Tate & Lyle, the company that manufactures sucralose. So before we get anywhere near the biology, hold onto that: the cleanup job was signed by the people with money on the table.

Now the biology, because it is genuinely unsettling. In 2023, a team led by Susan Schiffman, an adjunct professor in the joint biomedical engineering department at North Carolina State University and UNC Chapel Hill, looked not at sucralose itself but at a chemical cousin called sucralose-6-acetate. It is partly a manufacturing impurity, sitting in off-the-shelf sucralose at up to 0.67 percent before you ever tear the packet open, and partly something your own gut appears to generate after you swallow the stuff. When they exposed human blood cells to it, the molecule snapped DNA strands apart, a kind of damage called clastogenicity, and lit up positive on a micronucleus test, one of the standard bench assays for “this compound breaks chromosomes.” Schiffman’s own summary was not hedged: “It’s something you should not be eating.”

Then came the part that actually got me, where the biology stops being a number on a plate and starts being your body. When the team dripped sucralose and its acetate byproduct onto gut epithelial tissue, the lining that is supposed to be a tight, selective wall, the cells loosened their grip on each other. The tight junctions that seal one gut cell to the next came apart, and the wall turned leaky. Wait, why would a molecule shaped like sugar pry open the seams of your intestine? That is the question I kept circling. The best read of the data is that the compound stresses those cells directly: the gut tissue ramped up genes tied to oxidative stress, inflammation, and carcinogenicity, the cellular equivalent of an alarm going off. A leaky wall means things that should stay in the gut and leave your body instead slip into the bloodstream. The sweetener may not sit inertly on your tongue and pass through. It may be quietly renegotiating the border of your gut.

And there is a number that should have ended the argument on its own. The European Food Safety Authority sets a threshold of toxicological concern for genotoxic substances at 0.15 micrograms per person per day. Schiffman’s group calculated that a single daily sucralose-sweetened drink delivers more sucralose-6-acetate than that, before you even count what your digestion makes. By the regulator’s own line in the sand, the trace impurity in one diet soda clears the bar for “we should be worried about this.”

EFSA GENOTOXIC LIMIT
0.15 microgramsper person, per day
One daily sucralose-sweetened drink delivers more of the byproduct than this, before digestion adds any. Source: Schiffman et al., 2023

So how did damning become complicated? Two things pushed back. First, in February 2026, an EFSA panel re-evaluated sucralose and kept the acceptable daily intake right where it was, at 15 milligrams per kilogram of body weight, concluding no genotoxicity concern. Their move on the metabolite question is worth reading slowly: the compounds that showed up in the old rat studies, they suggested, might have been impurities already present in the dosed sucralose rather than something the body produced. Maybe. It is also the most convenient possible reading, and it steps neatly around the finding that the impurity alone, sitting in the packet, breaks the agency’s own threshold.

Second, in August 2026, a study in Food and Chemical Toxicology ran commercial-grade sucralose through a battery of modern assays, the Ames test, in vitro and in vivo micronucleus, a transgenic mouse mutation test, and found no genotoxic concern. Reassuring, until you read the author line. The August 2026 study now being cited to calm everyone down was co-written by Jaspreet Gujral of Tate & Lyle Solutions USA, the company that manufactures sucralose, working with the contract toxicology firm Intertek Health Sciences.

Set that beside the 2023 work. Schiffman’s team declared no conflict of interest and did the study on money from NC State’s Engineering Foundation. There was nothing to sell. The rebuttal came with a payroll. A conflict of interest is not proof of fraud, and I am not calling the manufacturer’s assays fake. It is exactly the fact you need when two studies point in opposite directions and somebody has to decide which one to believe. It matters, too, that the manufacturer’s team mostly tested sucralose, the parent molecule, not the acetate impurity that raised the flag in the first place. But when the lab that disclosed no conflict finds the byproduct breaks DNA and unseals the gut wall, and the maker’s own lab finds nothing to see here, “complicated” is not a neutral description of that standoff. It is a choice about whose homework to grade on a curve.

Here is the honest floor. All of this is bench work, human cells in a dish and animals, not a trial tracking real people who drink diet soda for twenty years. Nobody has run that trial. Sucralose has been on the market for more than two decades, in thousands of products, and the study that would actually settle whether this genotoxic signal reaches the humans consuming it has never been done. That absence is not reassurance. It is the scandal. The burden of proof belongs on the industry that profits and the regulators paid to check it, not on the one team that bothered to look and got waved off.

I still don’t think sugar is the hero of this story. But I’ve started turning packets over and scanning the fine print for sucralose, and when I find it, I put the product back. Not because a dish of cells is my body, but because when the conflict-free lab in this fight tells me a chemical snaps DNA and unseals my gut, and the pushback is signed by the manufacturer, I know whose read I trust to have my interests at heart. I would rather drink my coffee a little less sweet than wait twenty more years for a human trial nobody seems in a hurry to run.

Sources

  1. Journal of Toxicology and Environmental Health, Part B – Schiffman et al., “Toxicological and pharmacokinetic properties of sucralose-6-acetate and its parent sucralose: in vitro screening assays” (2023)
  2. EurekAlert – NC State release on the sucralose-6-acetate genotoxicity study
  3. SciTechDaily – Schiffman quotes, clastogenicity and leaky-gut findings
  4. Food and Chemical Toxicology – “Genotoxicity and mutagenicity of commercial-grade sucralose,” Gujral (Tate & Lyle) et al. (2026)
  5. EFSA Journal – Re-evaluation of sucralose (E 955) (2026)
  6. Food Safety Magazine – “EU Maintains Current Stance on Safety of Sucralose After Reevaluation”
  7. ScienceDaily – “Popular sweetener byproduct damages DNA in human cells” (Sept 2026)